Diabetes · Indianapolis area, IN
Diabetes studies in Indianapolis area, IN
17 recruiting studies have a site in the Indianapolis area. This page includes nearby cities such as Carmel, Fishers, Greenwood, Avon.
17 recruiting studiesSource: ClinicalTrials.gov, refreshed October 26, 2026How we list studies
Studies
- RecruitingHealthy volunteers
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
Cleerly, Inc.
- Location
- Indianapolis, IN + 121 other US sites
- Eligibility basics
- Ages 55+
- RecruitingPhase 3
A Clinical Trial of MK-8748 Compared to Aflibercept in Participants With Diabetic Macular Edema (MK-8748-004)
Merck Sharp & Dohme LLC
- Location
- Carmel, IN + 27 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Clinical Trial of MK-8748 Compared to Aflibercept in Participants With Diabetic Macular Edema (MK-8748-005)
Merck Sharp & Dohme LLC
- Location
- Carmel, IN + 18 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
A Study to Test Whether BI 1815368 Helps People With an Eye Condition Called Diabetic Macular Edema
Boehringer Ingelheim
- Location
- Carmel, IN + 21 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
Boehringer Ingelheim
- Location
- Avon, IN + 199 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes
SAb Biotherapeutics, Inc.
- Location
- Indianapolis, IN + 20 other US sites
- Eligibility basics
- Ages 5–40
- RecruitingPhase 2
A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
Eli Lilly and Company
- Location
- Brownsburg, IN + 24 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 3
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
Eli Lilly and Company
- Location
- Indianapolis, IN + 59 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
Eli Lilly and Company
- Location
- Indianapolis, IN + 28 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 1/Phase 2
CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)
COUR Pharmaceutical Development Company, Inc.
- Location
- Indianapolis, IN + 44 other US sites
- Eligibility basics
- Ages 12–35
- RecruitingPhase 2
INHALE-1st: Afrezza® For Youth With Newly-Diagnosed Type 1 Diabetes
Mannkind Corporation
- Location
- Indianapolis, IN + 9 other US sites
- Eligibility basics
- Ages 6–17
- RecruitingPhase 3
A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)
Eli Lilly and Company
- Location
- Indianapolis, IN + 39 other US sites
- Eligibility basics
- Ages 10–17
- Recruiting
Efficacy of the Omnipod® 6 System Compared With the Omnipod® 5 System
Insulet Corporation
- Location
- Indianapolis, IN + 10 other US sites
- Eligibility basics
- Ages 14–75
- RecruitingPhase 2
A Study of the Effect of ZT-01 on Night-time Hypoglycemia in Type 1 Diabetes
Zucara Therapeutics Inc.
- Location
- Indianapolis, IN + 36 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingHealthy volunteers
Finding Immune Nascent Type 1 Diabetes
Indiana University
- Location
- Indianapolis, IN
- Eligibility basics
- Ages 1–99
- RecruitingHealthy volunteers
A Sensory Strategy to Cut Sugary Beverages in African/American and Latine Adolescents
Nana Gletsu Miller
- Location
- Indianapolis, IN + 1 other US site
- Eligibility basics
- Ages 12–18
- RecruitingHealthy volunteers
TrialNet Pathway to Prevention of T1D
University of South Florida
- Location
- Indianapolis, IN + 16 other US sites
- Eligibility basics
- Ages 2–45
Who these studies look for
Studies commonly set an HbA1c range, a diagnosis duration and a list of allowed or excluded medications. Some also recruit people without diabetes as a comparison group.
Matching a page like this one never means you qualify. Each research team decides eligibility at screening.